Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy ; volume:23 ; number:1 ; day:17 ; month:4 ; year:2023 ; pages:1-13 ; date:12.2023
Cancer cell international ; 23, Heft 1 (17.4.2023), 1-13, 12.2023
- Urheber
-
Tsubaki, Masanobu
Takeda, Tomoya
Matsuda, Takuya
Kishimoto, Kana
Takefuji, Honoka
Taniwaki, Yuzuki
Ueda, Misa
Hoshida, Tadafumi
Tanabe, Kazufumi
Nishida, Shozo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-02884-z
- URN
-
urn:nbn:de:101:1-2023082911070746953039
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsubaki, Masanobu
- Takeda, Tomoya
- Matsuda, Takuya
- Kishimoto, Kana
- Takefuji, Honoka
- Taniwaki, Yuzuki
- Ueda, Misa
- Hoshida, Tadafumi
- Tanabe, Kazufumi
- Nishida, Shozo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Oxaliplatin-Associated Amaurosis Fugax
Oxaliplatin-induced lung fibrosis
Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
Prognostic value of cutaneous reinnervation with GAP-43 in oxaliplatin-induced neuropathy
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli